Open AccessLong-term Safety and Efficacy of Cabergoline for the Treatment of Idiopathic Restless Legs Syndrome: Results from an Open-Label 6-Month Clinical Trial
Author(s) -
Heike Beneš,
Claus R. Heinrich,
Michael A. Ueberall,
Ralf Kohnen
Publication year - 2004
Publication title -
sleep
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.222
H-Index - 207
eISSN - 1550-9109
pISSN - 0161-8105
DOI - 10.1093/sleep/27.4.674
Subject(s) - cabergoline , medicine , restless legs syndrome , adverse effect , nausea , bedtime , ropinirole , pediatrics , anesthesia , insomnia , parkinson's disease , levodopa , psychiatry , hormone , prolactin , disease
To assess the safety and efficacy of cabergoline in the treatment of idiopathic restless legs syndrome (RLS) patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom